Gynecologic and Obstetric Pathology

  • Continuing Education
image of doctor going over an OBG ultrasound with 2 patients

-

Registration Deadline: April 11, 2027

Explore the latest clinically relevant updates in gynecologic and obstetric pathology, with expert-led guidance on evolving classifications, diagnostic criteria, staging, and practice guidelines. Apply current knowledge through interactive lectures and real-world slide sessions focused on challenging diagnoses, differential diagnoses, and practical approaches for practicing pathologists.

  • Live Online

This course is taught in person.

 

Additionally, all sessions will be recorded and made available to participants for on-demand online viewing for 90 days after the end of the course.

$700

For a full list of profession pricing see below.
View All

Continuing Education

Earn up to:
22.75 AMA PRA Category 1 Credits™.
View All

Three Days

Please view the Schedule for a full description of the program.

On This Page

Overview

This inaugural course provides timely, clinically relevant and contemporary updates in the practice of Gynecologic and Obstetric Pathology. The course is organized and delivered by nationally and internationally renowned experts in gynecologic and obstetric pathology at Mass General Brigham.

Emphasis is given to important shifts in pathology definitions, classification, diagnostic criteria, and staging of gynecologic and obstetric conditions, reflecting recommendations by the World Health Organization Classification, the American Joint Committee on Cancer and International Federation of Obstetrics and Gynecology staging systems, and practice guidelines (such as the College of American Pathologists, International Collaboration on Cancer Reporting, the National Comprehensive Cancer Network, and the European Society of Gynecologic Oncology). Critical updates in each organ system and disease category are organized in dedicated lectures, focusing on practical guidance and rules for general practicing pathologists. About half of the course content is dedicated to slide sessions, in which illustrative examples of critical diagnostic entities and their differential diagnoses are discussed by the experts, mirroring a real-practice sign-out setting. Emerging and diagnostically challenging entities are covered in detail. Both lectures and slide sessions are designed to be interactive and promote participation by the audience.


Learning Objectives

  • Understand and apply in daily practice essential resources, including the upcoming WHO classification of tumors of the female reproductive system, the Amsterdam consensus guideline on placental pathology, the most recent updates to the FIGO staging systems, ICCR resources, and current NCCN guidelines for the management of patients with gynecologic cancer.
  • Identify the scenarios in which diagnosis of non-epithelial (mesenchymal, sex-cord stromal, gestational) gynecologic neoplasia, as per WHO criteria, requires molecular testing as an essential criterion, and how to proceed when such testing is not available.
  • Identify the most common pathologic lesions found in the placenta, understanding their relevance in terms of correlation with adverse maternal and fetal outcomes, recurrence in future gestations and need for immediate / prompt intervention.
  • Discuss the role of biomarker testing in the diagnosis, prognosis and management of patients with ovarian cancer, endometrial cancer, and cervical cancer.
  • Appraise emerging information on clinically relevant forms of endometrial, upper genital and mesenchymal gynecologic neoplasia.
  • Describe the novel classification systems for lower genital tract neoplasia including the currently recommended nomenclature.
  • Recognize forms of gestational trophoblastic neoplasia applying strict diagnostic criteria and judicious use of ancillary testing.

Developed and Offered By:

  • Mass General Brigham logo

Continuing Education courses are developed by faculty from Harvard Medical School's teaching hospitals and accredited by Harvard Medical School. This course is offered by Massachusetts General Brigham.

Who Should Participate

Pathologists, Specialty Physicians, and Others

Faculty

Harvard Medical School Continuing Education attracts the best and brightest faculty from all around the world. As a student in this course, you’ll have access to outstanding course directors and faculty.

 

Course Directors

Erin Alston, MD
Pathologist, Mass General Brigham
Instructor in Pathology, Harvard Medical School

John Chambers, BS
Senior Project Coordinator, Department of Pathology, Mass General Brigham

Benjamin Coiner, MD
Women's and Perinatal Pathology Fellow, Brigham and Women's Hospital

Katelyn Dannheim, MD
Pathologist, Mass General Brigham
Assistant Professor of Pathology, Harvard Medical School

Kyle Devins, MD
Pathologist, Mass General Brigham
Assistant Professor of Pathology, Harvard Medical School

Emily Hatheway-Marshall, MD
Women's and Perinatal Pathology Fellow, Brigham and Women's Hospital

Michelle Hirsch, MD, PhD
Pathologist, Mass General Brigham
Professor of Pathology, Harvard Medical School

Anjelica Hodgson, MD
Pathologist, University Health Network
Assistant Professor of Pathology, University of Toronto

Sarah Johnstone, MD, PhD
Pathologist, Mass General Brigham
Assistant Professor of Pathology, Harvard Medical School

Sarah Khan, MD
Women's and Perinatal Pathology Fellow, Brigham and Women's Hospital

David Kolin, MD, PhD
Pathologist, Mass General Brigham
Associate Professor of Pathology, Harvard Medical School

Andrew Leader, MD, PhD
Women's and Perinatal Pathology Fellow, Brigham and Women's Hospital

Lawrence Lin, MD, PhD
Pathologist, Mass General Brigham
Assistant Professor of Pathology, Harvard Medical School

Zehra Ordulu, MD
Pathologist, Mass General Brigham
Assistant Professor of Pathology, Harvard Medical School

Bradley Quade, MD, PhD
Pathologist, Mass General Brigham
Associate Professor of Pathology, Harvard Medical School

Lauren Ray, MD
Surgical Pathology Fellow, Massachusetts General Hospital

Aarti Sharma, MD
Pathologist, Mass General Brigham
Assistant Professor of Pathology, Harvard Medical School

Negar Taheri, MD
Anatomic Pathology Resident, Mass General Brigham

Dina Zenezan, MD
Surgical Pathology Fellow, Massachusetts General Hospital

Complete Your Registration

Started a registration? Log in to enroll today.

Log in to Access.

Request Information

Interested in learning more about this program? Sign up for details.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Course Fees

Registration Details

You may register through our secure online environment and will receive an email confirmation upon receipt of your payment. Prices include CME credit, electronic syllabus, and access to some recordings for 90 days after the course. At the end of the registration process, a $10 non-refundable processing fee will be added to your registration. 

Review the cancellation policy.

Role Course Fee
Physician (MD/DO) $700
Resident/Fellow $200
Allied Health Professional / Other $700

Accreditation

In support of improving patient care, Harvard Medical School is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Live/Live Online Courses: To receive CME/CE credit, learners are required to complete the course evaluation. Once the evaluation is complete, you will be able to claim your credit and download your certificate. All evaluations and credit claims must be completed within 60 days of the course end date.

Online Courses: To receive CME/CE credit, learners must pass the course post-test and complete the course evaluation in order to claim credit before the final day of the accreditation period. Learners have access to the course for 60 days after the accreditation period has expired.

The Harvard Medical School designates this live activity for a maximum of 22.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For the purpose of recertification, the National Commission on Certification of Physician Assistants, the American Academy of Nurse Practitioners Certification Board and the American Nurses Credentialing Center accept  AMA PRA Category 1 Credit™ issued by organizations accredited by the ACCME. We would also suggest that learners check with their state licensing board to ensure they accept reciprocity with  AMA PRA Category 1 Credit™ for re-licensure.

The National Commission on Certification of Physician Assistants (NCCPA) states that  AMA PRA Category 1 Credits™ are acceptable for continuing medical education requirements for recertification. We would also suggest that learners check with their state licensing board to ensure they accept reciprocity with AMA PRA Category 1 Credit™ for re-licensure. 

The American Medical Association (AMA) has an agreement of mutual recognition of continuing medical education (CME) credit with the European Union of Medical Specialists (UEMS). Additional information regarding this agreement may be found on the Union of European Medical Specialists website.

The Royal College of Physicians and Surgeons of Canada recognizes conferences and workshops held outside of Canada that are developed by a university, academy, hospital, specialty society or college as accredited group learning activities.

Competencies

This course is designed to meet the following Institute of Medicine Core Competencies:

  • Provide Patient-Centered Care
  • Work in Interdisciplinary Teams
  • Employ Evidence-Based Practice

This course is designed to meet the following American Board of Medical Specialties (ABMS) / Accreditation Council for Graduate Medical Educational (ACGME) competencies:

  • Patient Care and Procedural Skills
  • Medical Knowledge
  • Practice-Based Learning and Improvement
  • Systems-Based Practice
  • Interpersonal and Communication Skills

Disclaimer & Disclosure

CME activities accredited by Harvard Medical School are offered solely for educational purposes and do not constitute any form of certification of competency. Practitioners should always consult additional sources of information and exercise their best professional judgment before making clinical decisions of any kind.

Note: AMA PRA Category 1 Credit™ is calculated based on submission of a preliminary agenda and may be subject to change.

In accord with the disclosure policy of the Medical School as well as standards set forth by the Accreditation Council for Continuing Medical Education (ACCME), course planners, speakers, and content reviewers have been asked to disclose any relationships they have to companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. In addition, faculty have been asked to list any off-label uses of pharmaceuticals and/or devices for investigational or non-FDA approved purposes that they plan to discuss.

Registration for courses managed by Harvard Medical School can only be completed through Harvard Medical School’s official registration portal: cmeregistration.hms.harvard.edu. Attendee registrations made through any other sites cannot be honored and will not be refunded. Please report any unauthorized websites or solicitations for registrations.

In order to comply with applicable U.S. export control and sanctions regulations, Harvard Medical School prohibits access to and use of Harvard Medical School educational offerings, programs and resources to individuals from certain sanctioned regions or who are otherwise subject to U.S. government sanctions, unless appropriate authorization is in place.

Program Topics

Program Specialties